Michael Burry, famous for predicting 2008 crisis, made headlines with his latest 13F filing. He shifted towards commodities & renewable energy and decreased holdings in tech giants.
Cannabis producer Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) announced on Wednesday its financial and operating results for the first quarter ended March 31, 2024. "I want to thank the Cresco team for taking our learnings from the Year-of-the-Core, making them a part of our DNA and producing such a strong start to 2024," Charles Bachtell, CEO of Cresco Labs, said. "The continued development of our teams' capabilities and our relentless focus on efficient execution is leading to very strong performance across our retail and branded product business resulting in a 10x increase in operating cash flow year-over-year."
Trulieve Cannabis Corp. announced on Thursday its first quarter results for the three months ended March 31, 2024. The Tallahassee, Florida-based medical cannabis giant reported revenue of $298 million for the first quarter of fiscal 2024, representing an increase of 4% sequentially and year-over-year, with 96% of revenue from retail sales.
BofA Securities analyst Bryan Spillane boosts Colgate-Palmolive's target to $100, citing impressive growth metrics. CL started the year strong with +9.8% organic sales and EPS of $0.86, beating estimates. Pricing surged +8.5%, driving a significant margin expansion. Hyperinflation in select regions fueled performance, while North America saw notable market share gains, a testament to Colgate's marketing prowess.
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.